During the last session, Surgalign Holdings Inc. (NASDAQ:SRGA)’s traded shares were 1.88 million, with the beta value of the company hitting 2.13. At the end of the trading day, the stock’s price was $1.18, reflecting an intraday gain of 5.36% or $0.06. The 52-week high for the SRGA share is $3.41, that puts it down -188.98 from that peak though still a striking 8.47% gain since the share price plummeted to a 52-week low of $1.08. The company’s market capitalization is $166.06M, and the average intraday trading volume over the past 10 days was 3.07 million shares, and the average trade volume was 3.16 million shares over the past three months.
Surgalign Holdings Inc. (SRGA) received a consensus recommendation of a Buy from analysts. That translates to a mean rating of 1.70. SRGA has a Sell rating from 0 analyst(s) out of 7 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 7 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -$0.12.
Surgalign Holdings Inc. (NASDAQ:SRGA) trade information
Surgalign Holdings Inc. (SRGA) registered a 5.36% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 5.36% in intraday trading to $1.18 this Wednesday, 07/21/21, hitting a weekly high. The stock’s 5-day price performance is 6.31%, and it has moved by -13.87% in 30 days. Based on these gigs, the overall price performance for the year is -64.56%. The short interest in Surgalign Holdings Inc. (NASDAQ:SRGA) is 4.96 million shares and it means that shorts have 1.9 day(s) to cover.
The consensus price target of analysts on Wall Street is $4.71, which implies an increase of 74.95% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $3.00 and $8.00 respectively. As a result, SRGA is trading at a discount of -577.97% off the target high and -154.24% off the low.
Surgalign Holdings Inc. (SRGA) estimates and forecasts
Statistics show that Surgalign Holdings Inc. has underperformed its competitors in share price, compared to the industry in which it operates. Surgalign Holdings Inc. (SRGA) shares have gone down -42.16% during the last six months, with a year-to-date growth rate less than the industry average at 5.88% against 16.90. Yet analysts are ramping up their growth forecast for the fiscal year 2021. Revenue is predicted to grow 62.50% this quarter and then jump 9.10% in the quarter after that. In the rating firms’ projections, revenue will increase 6.00% compared to the previous financial year.
Revenue for the current quarter is expected to be $24.8 million as predicted by 6 analyst(s). Meanwhile, a consensus of 6 analyst(s) estimates revenue growth to $28.82 million by the end of Sep 2021. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled $48.74 million and $27.93 million respectively. In this case, analysts expect current quarter sales to shrink by -49.10% and then jump by 3.20% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -23.59%. While earnings are projected to return 26.40% in 2021, the next five years will return 15.00% per annum.
Surgalign Holdings Inc. is due to release its next quarterly earnings between August 10 and August 20. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Surgalign Holdings Inc. (NASDAQ:SRGA)’s Major holders
Surgalign Holdings Inc. insiders own 10.72% of total outstanding shares while institutional holders control 52.91%, with the float percentage being 59.27%. Blackrock Inc. is the largest shareholder of the company, while 137 institutions own stock in it. As of Mar 30, 2021, the company held over 6.5 million shares (or 5.89% of all shares), a total value of $14.18 million in shares.
The next largest institutional holding, with 6.45 million shares, is of Krensavage Asset Management, LLC’s that is approximately 5.84% of outstanding shares. At the market price on Mar 30, 2021, these shares were valued at $14.06 million.
Also, the Mutual Funds coming in first place with the largest holdings of Surgalign Holdings Inc. (SRGA) shares are SPDR (R) Ser Tr-SPDRï¿½ Kensho New Economies Composite ETF and Fidelity Strategic Advisors Small-Mid Cap Fund. Data provided on Jun 29, 2021 indicates that SPDR (R) Ser Tr-SPDRï¿½ Kensho New Economies Composite ETF owns about 4.11 million shares. This amounts to just over 3.72 percent of the company’s overall shares, with a $5.71 million market value. The same data shows that the other fund manager holds slightly less at 3.11 million, or about 2.82% of the stock, which is worth about $5.63 million.